Clinical Trial Update: Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating MN-221 in adults with stable moderate to severe chronic obstructive pulmonary disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• MN-221

Snippet

Sponsor: MediciNova | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED